CLINICAL RESEARCH GROUP RECRUITMENT AND RETENTION SHARED FACILITY (RRSF) ABSTRACT The Recruitment and Retention Shared Facility (RRSF) is an infrastructure designed to assist UAB-CCC investigators recruit participants for clinical research. The facility: 1) provides diverse recruitment services (developing recruitment strategies and materials; recruiting and scheduling subjects, etc.); 2) provides the necessary linkage between CCC researchers and surrounding communities; 3) maintains information systems with a Recruitment Data Base (RDB), a Recruitment Tracking System (RTS), a Health Profile System (HPS), to identify subjects of interest to investigators; and 4) tracks and promotes retention through the Patient Navigation System and the Recruitment Tracking system. Since 1997 the RRSF demonstrated success in recruiting participants primarily for large population-based clinical trials. More than 24,000 participants were recruited for more than 23 cancer studies; 32% of these participants were African American, and 78% were women. Census data show that Alabama residents are 26.6% African American and 4% Hispanic. Hispanics in Alabama are mainly young immigrants and have low incidence of cancer. Due to these factors, the RRSF decided to focus recruitment efforts on one of our minority populations. The RRSF continues to recruit for population-based studies, but has decided to address the needs of UAB-CCC investigators and focus on piloting new strategies to recruit participants for therapeutic clinical trials. A model program was implemented entitled, Increasing Minority Participation in Clinical Trials through Patient Navigation (IMPaCT-PN). IMPaCT- PN, which aims to provide equal access to clinical trials for low-resource and African American patients by helping them overcome barriers to participation and navigate the healthcare system. In 2009, the NIMHD awarded UAB a U24 grant to create a National Comprehensive Cancer Centers Consortium to implement and evaluate new strategies to enhance minority enrollment in clinical research with a main focus on patient navigation. UAB serves as the lead institution providing training to implement the IMPaCT Patient Navigation Program at the cancer centers of University of Minnesota, University of Texas-MD Anderson, Johns Hopkins University, and the University of California-Davis. RRSF is a unique shared facility that provides a centralized infrastructure, databases, and staff with recruitment expertise so investigators do not have to build recruitment teams for each new study.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013148-46
Application #
9467451
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-04-01
Budget End
2019-03-31
Support Year
46
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Alabama Birmingham
Department
Type
DUNS #
063690705
City
Birmingham
State
AL
Country
United States
Zip Code
35294
Carson, Tiffany L; Wang, Fuchenchu; Cui, Xiangqin et al. (2018) Associations Between Race, Perceived Psychological Stress, and the Gut Microbiota in a Sample of Generally Healthy Black and White Women: A Pilot Study on the Role of Race and Perceived Psychological Stress. Psychosom Med 80:640-648
Williams, Adele P; Waters, Alicia M; Stewart, Jerry E et al. (2018) A novel retinoid X receptor agonist, UAB30, inhibits rhabdomyosarcoma cells in vitro. J Surg Res 228:54-62
Frugé, Andrew D; Cases, Mallory G; Howell, Carrie R et al. (2018) Fingernail and toenail clippings as a non-invasive measure of chronic cortisol levels in adult cancer survivors. Cancer Causes Control 29:185-191
McCaw, Tyler R; Randall, Troy D; Arend, Rebecca C (2018) Overcoming immune suppression with epigenetic modification in ovarian cancer. Transl Res :
Geng, Mengxin; Austin, Frank; Shin, Ronald et al. (2018) Covalent Structure and Bioactivity of the Type AII Lantibiotic Salivaricin A2. Appl Environ Microbiol 84:
Samykutty, Abhilash; Grizzle, William E; Fouts, Benjamin L et al. (2018) Optoacoustic imaging identifies ovarian cancer using a microenvironment targeted theranostic wormhole mesoporous silica nanoparticle. Biomaterials 182:114-126
Friedman, Gregory K; Bernstock, Joshua D; Chen, Dongquan et al. (2018) Enhanced Sensitivity of Patient-Derived Pediatric High-Grade Brain Tumor Xenografts to Oncolytic HSV-1 Virotherapy Correlates with Nectin-1 Expression. Sci Rep 8:13930
Powell, T Clark; Dilley, Sarah E; Bae, Sejong et al. (2018) The Impact of Racial, Geographic, and Socioeconomic Risk Factors on the Development of Advanced-Stage Cervical Cancer. J Low Genit Tract Dis 22:269-273
Kasten, Benjamin B; Oliver, Patsy G; Kim, Harrison et al. (2018) 212Pb-Labeled Antibody 225.28 Targeted to Chondroitin Sulfate Proteoglycan 4 for Triple-Negative Breast Cancer Therapy in Mouse Models. Int J Mol Sci 19:
Subramaniam, Akila; Blanchard, Christina T; Erickson, Britt K et al. (2018) Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial. Obstet Gynecol 132:20-27

Showing the most recent 10 out of 747 publications